The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
- PMID: 36352920
- PMCID: PMC9638621
- DOI: 10.4103/jfmpc.jfmpc_16_22
The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
Abstract
Background/aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer.
Settings and design: Medical records of all patients above the age of 50 years who had visited the Family Medicine clinic at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia and who had undergone the FOBT screening between January 2002 and March 2017 were retrospectively reviewed.
Materials and methods: We collected patients' demographic data, FOBT results, and colonoscopy pathology reports results.
Statistical analysis: Data were analyzed using the Statistical Package for Social Science Version 25 (IBM Corp., Armonk, NY, USA).
Results: We included 2179 patients in this study. The mean age was 59.8 ± 8 years. As a result of the FOBT screening, 19.7% of the patients had a positive FOBT. Colon cancer accounted for 3.5% of all abnormal colonoscopy pathology reports. The Saudi age-standardized incidence rate (ASIR) in our study was 26.56 per 100,000 persons.
Conclusion: FOBT is a feasible tool that can be used for colon cancer screening in primary care settings. The Saudi ASIR in our study was higher than the Saudi Cancer Registry, but it was still lower in comparison to other countries. We recommend the establishment of a national community-based colon cancer screening program.
Keywords: Colon cancer; FOBT; Saudi Arabia; colonic polyps; colonoscopy; screening.
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults.Cureus. 2023 Aug 10;15(8):e43312. doi: 10.7759/cureus.43312. eCollection 2023 Aug. Cureus. 2023. PMID: 37700965 Free PMC article.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300. World J Gastroenterol. 2012. PMID: 22969192 Free PMC article.
-
Fecal occult blood test screening for colorectal cancer.Gastrointest Endosc Clin N Am. 2002 Jan;12(1):11-21. doi: 10.1016/s1052-5157(03)00054-0. Gastrointest Endosc Clin N Am. 2002. PMID: 11916154 Review.
-
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
Cited by
-
Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update.Bioinformation. 2024 Apr 30;20(4):397-403. doi: 10.6026/973206300200397. eCollection 2024. Bioinformation. 2024. PMID: 38854755 Free PMC article.
-
Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults.Cureus. 2023 Aug 10;15(8):e43312. doi: 10.7759/cureus.43312. eCollection 2023 Aug. Cureus. 2023. PMID: 37700965 Free PMC article.
-
Colon Cancer Screening Methods: 2023 Update.Cureus. 2023 Apr 12;15(4):e37509. doi: 10.7759/cureus.37509. eCollection 2023 Apr. Cureus. 2023. PMID: 37193451 Free PMC article. Review.
-
Doing things right and doing the right things: Colorectal cancer screening in Saudi Arabia.Saudi J Gastroenterol. 2023 Mar-Apr;29(2):67-70. doi: 10.4103/sjg.sjg_82_23. Saudi J Gastroenterol. 2023. PMID: 36960528 Free PMC article. No abstract available.
References
-
- World Health Organization and International Agency for Research on Cancer. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lyon, France: Lung Cancer GLOBOCAN; 2012.
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials